News | December 22, 2008

St. Jude Medical Acquires Radi Medical Systems to Expand Cardiovascular Offerings

December 23, 2008 - St. Jude Medical Inc. said this week it completed the acquisition of Radi Medical Systems AB for $250 million in cash.

Radi is a leader in two segments of the market for cardiovascular medical devices in which St. Jude Medical does not currently participate - fractional flow reserve pressure measurement guide wires and manual compression-assist products for vascular closure. For 2008, Radi is expected to generate approximately $80 million in sales, a 19 percent increase over 2007.

Radi’s pressure measurement guide wire, PressureWire Certus, comprises about a 70 percent share of the global market for physiological assessment of coronary lesions. The product is supported by a growing body of clinical evidence, including the FAME (Fractional Flow Reserve vs. Angiography for Multivessel Evaluation) study. The results of the FAME study were presented at the Transcatheter Cardiovascular Therapeutics conference in October 2008. The market for physiological assessment of coronary lesions totaled more than $60 million in 2008 and is projected to continue growing at a strong double-digit rate, St. Jude said

Radi’s FemoStop and RadiStop product lines comprise about a 60 percent share of the global market for manual compression-assist products for vascular closure. This market totaled about $45 million in 2008 and is projected to continue to grow at least at a mid single-digit rate. The FemoStop and RadiStop product lines, together with St. Jude Medical’s Angio-Seal line of active vascular closure products, will be part of an expanded program by St. Jude to develop the potential of a global vascular closure device market that is only about 27 percent penetrated, the company said.

With this transaction, Radi Medical Systems will become part of the St. Jude Medical Cardiovascular Division. The transaction is expected to be neutral to St. Jude Medical’s consolidated earnings per share in 2009 and is expected to be positive to consolidated earnings per share beginning in 2010. St. Jude Medical funded the acquisition with cash on hand outside the U.S. as well as with the proceeds from a new three-year term loan established recently with a syndicate of banks.

For more information: www.sjm.com, www.radi.se, www.famestudy.com


Related Content

News | Catheters

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

Home December 05, 2022
Home
Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...

Home February 09, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
News | Catheters

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The ...

Home February 21, 2019
Home
Subscribe Now